BDBM50040753 CHEMBL2371459::[(7S,13S,16R)-4-Carbamoyl-13-(3-guanidino-propyl)-16-(2-mercapto-propionylamino)-3,3,14-trimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid
SMILES [#6]-[#6](-[#16])-[#6](=O)-[#7]-[#6@H]-1-[#6]-[#16]-[#16]C([#6])([#6])[#6@@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#7](-[#6])-[#6]-1=O)-[#6](-[#7])=O
InChI Key InChIKey=DHOGUPWBMAGBOA-UHFFFAOYSA-N
Data 1 KI
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 50040753
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Affinity DataKi: 24.3nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
